Financial Impact Assessment
What Is the EEG Gap Costing Your Hospital?
Estimate the annual revenue leaving with EEG-related transfers, the bed days lost to diagnostic delay, and the whole-picture opportunity when pediatric and point-of-care EEG stay in-house. Adjust any input to reflect your facility's actual data.
Your Facility Inputs
1
EEG-Related Transfers
▼
Monthly Neurology Transfers Out ★ Required
The average number of neurology patients transferred to another facility each month. Your transfer center or case management team can provide this figure.
pts/mo
Share of Transfers Related to EEG Access Customize
The percentage of neurology transfers driven by the inability to obtain or interpret an EEG locally — seizure workups, altered mental status, and status epilepticus rule-outs. Published analyses identify roughly 20% of tertiary neuroscience transfers as potentially avoidable overall2; the default is a planning assumption for facilities without local interpretation, not a published rate. Validate with your transfer logs: count neurology transfers over 6–12 months with a documented "EEG or monitoring unavailable" reason, and replace this default with your actual share.
%
Net Revenue Lost Per Transfer Benchmark 1
Definition: the net patient revenue that leaves with each transferred episode — admission, diagnostics, ancillaries, and professional fees, net of contractual adjustments. Published transfer analyses place this above $15,000 per transfer1. For the most conservative view, enter your contribution margin per neurology admission instead (published average ≈ $10,8001). Your finance team can supply either figure by MS-DRG; seizure admissions are MS-DRG 100–101.
$
/transfer
Share Retainable With 24/7 EEG Coverage Customize
A conservative planning factor for the share of EEG-related transfers that could remain local with on-demand interpretation in place. The default of 72% applies only to transfers classified as EEG-related in the field above — when EEG access is the documented reason for transfer, providing that access removes the driver. Some patients will still require tertiary care regardless. Validate with a chart sample: review 20–30 EEG-related transfers and classify each as "transferred solely for EEG access" versus "needed higher-level care anyway."
%
2
Length of Stay & Throughput
▼
Monthly EEG Orders ★ Required
Total inpatient EEG studies ordered per month — or, if EEG is unavailable, the estimated monthly demand your neurodiagnostics team believes exists.
/mo
Bed Days Added Per Study by EEG Delay Customize
The average length-of-stay added while patients wait for an EEG or its interpretation. Economic modeling of rapid EEG access documents 1.1 fewer hospital days per patient when the EEG answer arrives sooner4; the default reflects a conservative fraction of that finding.
days
Value Per Inpatient Bed Day Benchmark 7
The combined cost-avoidance and backfill value of a recovered bed day. AHA Hospital Statistics places the average cost per inpatient day near $2,8007; the default is set conservatively below that figure.
$
/day
3
Pediatric / Neonatal EEG
▼
Monthly Pediatric / NICU EEG Cases Sent Out ★ Required
Pediatric and neonatal patients transferred out — or studies sent to an outside reader — because pediatric EEG interpretation is not available locally each month.
/mo
Revenue Lost Per Pediatric Case Customize
Pediatric transfers frequently involve specialized transport and longer tertiary stays, and each one moves a family's care relationship — deliveries, pediatrics, ED visits — out of your system. Set this to your pediatric case-mix value; the default reflects the episode alone, not the downstream family relationship.
$
/case
Share Retainable With Pediatric Coverage Customize
Set conservatively below the adult retention factor — some pediatric and neonatal cases genuinely require tertiary or children's hospital care regardless of local EEG access.
%
4
Point-of-Care EEG
▼
Monthly Suspected-Seizure Presentations ★ Required
ED and ICU patients each month with altered mental status or suspected seizure where an EEG answer would change management. Electrographic seizures are detected in roughly 19% of monitored critically ill patients, and most are nonconvulsive — invisible without EEG6.
/mo
Share Where Bedside EEG Informs Care Customize
In the multicenter DECIDE trial, point-of-care EEG changed clinical management in approximately 40% of patients with suspected seizures5. The default is set below the trial finding as a conservative planning assumption.
%
Savings Per Informed Case Benchmark 4
Peer-reviewed economic modeling found rapid-access EEG saved $5,633 per use case, driven by 1.1 fewer hospital days and 0.5 fewer ICU days per patient — largely from avoided empiric treatment and unnecessary ICU escalation4. Point-of-care EEG has also been shown to shorten ICU length of stay versus conventional EEG in multicenter trial data3.
$
/case
Monthly Transfers Avoided by Bedside Rule-Out Customize
Patients who would otherwise transfer for "possible seizure" who stay when a bedside EEG answers the question in minutes. Valued at your revenue-lost-per-transfer figure from Section 1.
/mo
5
Program Investment (Optional)
▼
Estimated Annual Program Investment Customize
Optional. Enter an estimated annual program cost to see net annual impact, return multiple, and payback period. Leave at zero to view the gross opportunity only.
$
/yr
Estimated Annual Financial Impact
Transfer Revenue Retained
...
EEG-related transfer cases kept in-house annually
Bed Days & Throughput Recovered
...
Value of bed days lost to EEG diagnostic delay
Pediatric / Neonatal Retention
...
Pediatric cases — and families — kept in your system
Point-of-Care Utilization Avoided
...
Avoided ICU escalation, empiric treatment, and rule-out transfers
Net Annual Impact
...
What Drives This Estimate
How This Is Calculated
Annual Opportunity by Program Module
Traditional TeleEEG — routine, STAT, and long-term video EEG — is the base program. Pediatric/Neonatal and Point-of-Care are opt-in expansions that run on the same implementation, workflow, and clinical team. Toggle modules above to include them.
| Module | Driver | Annual Value |
|---|
Why Studies Leave — and What Keeps Them
Without on-demand interpretation, an EEG order becomes a transfer decision. Nearly 20% of transfers to tertiary neuroscience services have been identified as potentially avoidable2, and among critically ill patients, most seizures are nonconvulsive — undetectable without an EEG at the bedside6. Every study read in-house keeps the patient, the episode revenue, and the downstream relationship — epilepsy and seizure patients alone generate an average of $8,388 in downstream reimbursement per patient8 — inside your walls.
For Your CFO — "What does this do to margin?"
For Your CEO — "What does this do to our market?"
For Your COO — "What does this do to throughput?"
Get your assessment.
Enter your name and email to receive a branded PDF of these results. Figures are illustrative planning estimates.
Benchmark Sources
- 1 Transfer economics: the default reflects net patient revenue per transferred episode. Published interfacility transfer analyses, 2024–2025, place combined transfer cost and lost episode value above $15,000; published average contribution margin per inpatient admission — the most conservative measure of loss — is approximately $10,800. Substitute your facility's net revenue or contribution margin by MS-DRG (seizure admissions: MS-DRG 100–101).
- 2 Identification and Cost of Potentially Avoidable Transfers to a Tertiary Care Neurosurgery Service: A Pilot Study. Neurosurgery. 2016. (Nearly 20% of transfers identified as potentially avoidable; $1.46M direct transport cost over two years.)
- 3 Evaluating the Impact of Point-of-Care Electroencephalography on Length of Stay in the Intensive Care Unit: Subanalysis of the SAFER-EEG Trial. Neurocritical Care. 2024.
- 4 Ney JP et al. Modeling the economic value of rapid response EEG in the inpatient hospital setting. Journal of Medical Economics. 2021. ($5,633 saved per use case; hospital LOS reduced 1.1 days; ICU LOS reduced 0.5 days.)
- 5 Vespa PM et al. Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study. Critical Care Medicine. 2020. (Point-of-care EEG changed clinical management in ~40% of patients.)
- 6 Claassen J et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004. (Seizures detected in 19% of monitored patients; 92% nonconvulsive.)
- 7 AHA Hospital Statistics. 2024. (Average cost per inpatient day approximately $2,800.)
- 8 Callaghan BC et al. Downstream Revenue Generated After Visits to Neurologists. Neurology Clinical Practice. 2025. (Epilepsy/seizure downstream reimbursement: $8,388 mean per patient; Medicare claims analysis, 2015–2019.)
Financial Impact Assessment
EEG Financial
Impact Assessment
Impact Assessment
Program scope:
Total Annual Opportunity
Results Summary
What Drives This Estimate
How This Is Calculated
Executive View
For Your CFO — "What does this do to margin?"
For Your CEO — "What does this do to our market?"
For Your COO — "What does this do to throughput?"
Your Inputs
| Input | Type | Value |
|---|
Benchmark Sources
- Transfer economics: the default reflects net patient revenue per transferred episode. Published interfacility transfer analyses, 2024–2025, place combined transfer cost and lost episode value above $15,000; published average contribution margin per inpatient admission — the most conservative measure of loss — is approximately $10,800. Substitute your facility's net revenue or contribution margin by MS-DRG (seizure admissions: MS-DRG 100–101).
- Identification and Cost of Potentially Avoidable Transfers to a Tertiary Care Neurosurgery Service: A Pilot Study. Neurosurgery. 2016.
- Evaluating the Impact of Point-of-Care Electroencephalography on Length of Stay in the Intensive Care Unit: Subanalysis of the SAFER-EEG Trial. Neurocritical Care. 2024.
- Ney JP et al. Modeling the economic value of rapid response EEG in the inpatient hospital setting. Journal of Medical Economics. 2021.
- Vespa PM et al. The DECIDE Multicenter Prospective Observational Clinical Study. Critical Care Medicine. 2020.
- Claassen J et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004.
- AHA Hospital Statistics. 2024.
- Callaghan BC et al. Downstream Revenue Generated After Visits to Neurologists. Neurology Clinical Practice. 2025.
Important note: This assessment produces illustrative estimates based on published benchmarks, planning assumptions, and user-entered inputs. Results are provided for informational and planning purposes only; they do not constitute a financial projection, a guarantee of savings or revenue, or financial, legal, reimbursement, or clinical advice. Actual results will vary based on facility volumes, payer mix, market conditions, and program configuration. Please validate all figures against your own data before use in budgeting or formal decision-making. | 866.785.7769 | marketing@tstelemed.com | tstelemed.com | © 2026 TeleSpecialists®. All Rights Reserved.